Latest NS5 Stories

2009-05-14 16:01:00

FREDERICK, Md., May 14 /PRNewswire/ -- ImQuest Bio and Arisyn jointly presented important new results on ATI-0810 (Formerly PG301029), a novel late stage inhibitor of hepatitis C virus (HCV) replication, at the 13th ISVHLD meeting held last week in Washington D.C.

2009-03-18 11:49:00

BRISBANE, Calif., March 18 /PRNewswire-FirstCall/ -- InterMune, Inc.

2009-02-24 07:55:00

PALO ALTO, Calif., Feb. 24 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc., a start-up biotechnology company developing antiviral therapies, announced that it has raised $7.1 million in a Series A financing co-led by InterWest Partners and Vivo Ventures.

2008-10-09 12:00:39

Genelabs Technologies, Inc. (Nasdaq:GNLB) announced that three presentations were made at the 15th International Symposium on Hepatitis C Virus and Related Viruses, each on a non-nucleoside hepatitis C virus (HCV) polymerase inhibitor discovered by Genelabs.

2008-09-24 09:00:13

BRISBANE, Calif., Sept. 24 /PRNewswire-FirstCall/ -- InterMune, Inc. today announced that four abstracts from clinical and in-vitro studies of ITMN-191 (R7227) accepted for presentation at the 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, Oct. 31 - Nov.

Word of the Day
  • To play, gamble.
  • To impose upon; delude; trick; humbug; also, to joke; chaff.
  • A deceitful game or trick; trickery; humbug; nonsense.
The word 'gammon' in the sense of 'joke, trick' may come from 'backgammon'.